ofloxacin has been researched along with Lymphoma, Non-Hodgkin in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with newly diagnosed haematological malignancy were given ofloxacin, 400 mg daily orally, for antibacterial prophylaxis during neutropenia." | 3.68 | Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy. ( Blundell, EL; Brown, NM; Chown, SR; MacGowan, AP; Reeves, DS; Slade, RR; White, LO, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, NM | 1 |
| White, LO | 1 |
| Blundell, EL | 1 |
| Chown, SR | 1 |
| Slade, RR | 1 |
| MacGowan, AP | 1 |
| Reeves, DS | 1 |
| Bertini, M | 1 |
| Freilone, R | 1 |
| Vitolo, U | 1 |
| Botto, B | 1 |
| Ciotti, R | 1 |
| Cinieri, S | 1 |
| Di Nota, A | 1 |
| Di Vito, F | 1 |
| Levis, A | 1 |
| Orsucci, L | 1 |
| Pini, M | 1 |
| Rota-Scalabrini, D | 1 |
| Todeschini, G | 1 |
| Resegotti, L | 1 |
| D'Antonio, D | 1 |
| Pizzigallo, E | 1 |
| Iacone, A | 1 |
| Dell'Isola, M | 1 |
| Fioritoni, G | 1 |
| Betti, S | 1 |
| Piergallini, A | 1 |
| Di Gianfilippo, R | 1 |
| Olioso, P | 1 |
| Torlontano, G | 1 |
1 trial available for ofloxacin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chem | 1996 |
2 other studies available for ofloxacin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Intest | 1993 |
Occurrence of bacteremia in hematologic patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Fe | 1992 |